⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACRS News
Aclaris Therapeutics, Inc.
Aclaris Therapeutics Completes Enrollment in Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
globenewswire.com
ACRS
Cowboys Golf Club Unveils Multi-Million-Dollar Transformation
businesswire.com
ACRS
Form 8-K
sec.gov
ACRS
Form 8-K
sec.gov
ACRS
Aclaris Therapeutics to Participate in the Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
ACRS
Excess Share Insurance (ESI) Launches Campio™ Powered by Acrisure®
prnewswire.com
ACRS
Form 8-K
sec.gov
ACRS
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
ACRS
Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Patients with Asthma with its Novel Bispecific Anti-TSLP/IL-4Rα Antibody ATI-052
globenewswire.com
ACRS
Aclaris Therapeutics to Participate in Two February Healthcare Conferences
globenewswire.com
ACRS